ML20054G402

From kanterella
Jump to navigation Jump to search
Requests Evidence That Fda Has Accepted Ind to Use Approved Radionuclides for Other Procedures.License Will Be Amended Accordingly
ML20054G402
Person / Time
Issue date: 11/09/1976
From: Bowyer J
NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
To:
ST. VINCENTS MEDICAL CENTER, BRIDGEPORT, CT
Shared Package
ML20054G353 List:
References
FRN-47FR15801, RULE-PR-50 NUDOCS 8206210522
Download: ML20054G402 (1)


Text

-

c0Sanas%

UNITED ETATES p

y NUCLEAR REGULATORY COMMISSION D

r j

WASHINGTON,0. C. 20556

\\powy$

FCYL:JEB NYS 1976

[p6[

(71607)

<1 l

\\]\\)

l bI v'Ty [4ff fp St. Vi ent'_sJ4 spital 0

Hospital Administrator]

ATTN:

m[

)

2820 Main u eet 1

Bridgeport, Connecticut 06606 Gentlenen:

This is in response to your letter dated July 29, 1976. Your byproduct material license authorizes you to use the radiophannaceuticals listed in your letter only for those procedures specified in Groups II t.hrough e

l IV, Section 35.100 of 10 CFR Part 35.

If you submit evidence that the Food and Drug Administration has accepted an IND to use approved radio-nuclides for other procedures, we will amend your license accordingly.

Sincerely,

~-

I M

J hn E. Bowyer Radioisotopes Licensing Branch Division of Fuel Cycle and Material Safety ik75 Q <W Al R.V s

11 c, c, %

pc[c p@C n,*[d C<-

8206210522 820611 a

s t unt pnn

._______.__m